MitoRx Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- MitoRx Therapeutics's estimated annual revenue is currently $1.4M per year.
- MitoRx Therapeutics's estimated revenue per employee is $77,500
- MitoRx Therapeutics's total funding is $8M.
Employee Data
- MitoRx Therapeutics has 18 Employees.
- MitoRx Therapeutics grew their employee count by 20% last year.
MitoRx Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Co-Founder and Director | Reveal Email/Phone |
3 | Inventor, Co-Founder and CSO | Reveal Email/Phone |
4 | Chief Discovery Officer | Reveal Email/Phone |
5 | VP Drug Discovery | Reveal Email/Phone |
6 | Head Preclinical Research | Reveal Email/Phone |
7 | Finance Director | Reveal Email/Phone |
8 | Finance Director | Reveal Email/Phone |
9 | Senior Discovery Scientist | Reveal Email/Phone |
10 | Chairman | Reveal Email/Phone |
MitoRx Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.4M | 18 | 20% | $7.94M | N/A |
#2 | $0.5M | 6 | 50% | N/A | N/A |
#3 | $1M | 13 | 0% | N/A | N/A |
#4 | $4.7M | 61 | 56% | N/A | N/A |
What Is MitoRx Therapeutics?
MitoRx Therapeutics is a pre-clinical stage rare disease biotech company aiming to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction, with a focus on neuromuscular disease, metabolic disease and neurodegenerative disease.
keywords:N/A
$8M
Total Funding
18
Number of Employees
$1.4M
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Oxford
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.3M | 18 | 0% | N/A |
#2 | $1M | 18 | 29% | N/A |
#3 | $1.4M | 18 | 0% | N/A |
#4 | $2.8M | 18 | 6% | N/A |
#5 | $2.2M | 18 | N/A | N/A |